266 related articles for article (PubMed ID: 17440622)
1. Epicutaneous immunization with type II collagen inhibits both onset and progression of chronic collagen-induced arthritis.
Strid J; Tan LA; Strobel S; Londei M; Callard R
PLoS One; 2007 Apr; 2(4):e387. PubMed ID: 17440622
[TBL] [Abstract][Full Text] [Related]
2. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of Th1-mediated pathology in experimental arthritis by stimulation of the Th2 arm of the immune response.
Mauri C; Feldmann M; Williams RO
Arthritis Rheum; 2003 Mar; 48(3):839-45. PubMed ID: 12632440
[TBL] [Abstract][Full Text] [Related]
4. Induction of IL-10-producing CD4+CD25+ T cells in animal model of collagen-induced arthritis by oral administration of type II collagen.
Min SY; Hwang SY; Park KS; Lee JS; Lee KE; Kim KW; Jung YO; Koh HJ; Do JH; Kim H; Kim HY
Arthritis Res Ther; 2004; 6(3):R213-9. PubMed ID: 15142267
[TBL] [Abstract][Full Text] [Related]
5. Epicutaneous immunization converts subsequent and established antigen-specific T helper type 1 (Th1) to Th2-type responses.
Strid J; Callard R; Strobel S
Immunology; 2006 Sep; 119(1):27-35. PubMed ID: 16764688
[TBL] [Abstract][Full Text] [Related]
6. The influence of HLA-DR4 (0401) on the immune response to type II collagen and the development of collagen induced arthritis in mice.
Wang D; Hill JA; Cairns E; Bell DA
J Autoimmun; 2002 Mar; 18(2):95-103. PubMed ID: 11908942
[TBL] [Abstract][Full Text] [Related]
7. Induction of Th2 cytokines and control of collagen-induced arthritis by nondepleting anti-CD4 Abs.
Chu CQ; Londei M
J Immunol; 1996 Sep; 157(6):2685-9. PubMed ID: 8805674
[TBL] [Abstract][Full Text] [Related]
8. Modulation of established murine collagen-induced arthritis by a single inoculation of short-term lipopolysaccharide-stimulated dendritic cells.
Salazar L; Aravena O; Abello P; Escobar A; Contreras-Levicoy J; Rojas-Colonelli N; Catalán D; Aguirre A; Zúñiga R; Pesce B; González C; Cepeda R; Cuchacovich M; Molina MC; Salazar-Onfray F; Delgado M; Toes RE; Aguillón JC
Ann Rheum Dis; 2008 Sep; 67(9):1235-41. PubMed ID: 18056756
[TBL] [Abstract][Full Text] [Related]
9. Antigen-induced, tolerogenic CD11c+,CD11b+ dendritic cells are abundant in Peyer's patches during the induction of oral tolerance to type II collagen and suppress experimental collagen-induced arthritis.
Min SY; Park KS; Cho ML; Kang JW; Cho YG; Hwang SY; Park MJ; Yoon CH; Min JK; Lee SH; Park SH; Kim HY
Arthritis Rheum; 2006 Mar; 54(3):887-98. PubMed ID: 16508971
[TBL] [Abstract][Full Text] [Related]
10. Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells.
Nandakumar KS; Bäcklund J; Vestberg M; Holmdahl R
Arthritis Res Ther; 2004; 6(6):R544-50. PubMed ID: 15535832
[TBL] [Abstract][Full Text] [Related]
11. Potent adjuvant effect by anti-CD40 in collagen-induced arthritis. Enhanced disease is accompanied by increased production of collagen type-II reactive IgG2a and IFN-gamma.
Tellander AC; Michaëlsson E; Brunmark C; Andersson M
J Autoimmun; 2000 Jun; 14(4):295-302. PubMed ID: 10882055
[TBL] [Abstract][Full Text] [Related]
12. Suppression of collagen-induced arthritis by oral or nasal administration of type II collagen.
Garcia G; Komagata Y; Slavin AJ; Maron R; Weiner HL
J Autoimmun; 1999 Nov; 13(3):315-24. PubMed ID: 10550219
[TBL] [Abstract][Full Text] [Related]
13. Conversion in vivo from an early dominant Th0/Th1 response to a Th2 phenotype during the development of collagen-induced arthritis.
Doncarli A; Stasiuk LM; Fournier C; Abehsira-Amar O
Eur J Immunol; 1997 Jun; 27(6):1451-8. PubMed ID: 9209498
[TBL] [Abstract][Full Text] [Related]
14. Curcumin attenuates inflammatory response in IL-1beta-induced human synovial fibroblasts and collagen-induced arthritis in mouse model.
Moon DO; Kim MO; Choi YH; Park YM; Kim GY
Int Immunopharmacol; 2010 May; 10(5):605-10. PubMed ID: 20188213
[TBL] [Abstract][Full Text] [Related]
15. Engagement of the CD137 (4-1BB) costimulatory molecule inhibits and reverses the autoimmune process in collagen-induced arthritis and establishes lasting disease resistance.
Foell JL; Diez-Mendiondo BI; Diez OH; Holzer U; Ruck P; Bapat AS; Hoffmann MK; Mittler RS; Dannecker GE
Immunology; 2004 Sep; 113(1):89-98. PubMed ID: 15312139
[TBL] [Abstract][Full Text] [Related]
16. CD25+ regulatory cells from HLA-DQ8 transgenic mice are capable of modulating collagen-induced arthritis.
Morgan ME; Witteveen HJ; Sutmuller RP; de Vries RR; Toes RE
Hum Immunol; 2004 Nov; 65(11):1319-27. PubMed ID: 15556682
[TBL] [Abstract][Full Text] [Related]
17. Vaccination with an immunodominant peptide of bovine type II collagen induces an anti-TCR response, and modulates the onset and severity of collagen-induced arthritis.
Honda A; Ametani A; Matsumoto T; Iwaya A; Kano H; Hachimura S; Ohkawa K; Kaminogawa S; Suzuki K; Sercarz EE; Kumar V
Int Immunol; 2004 May; 16(5):737-45. PubMed ID: 15096482
[TBL] [Abstract][Full Text] [Related]
18. Involvement of lymphocytes with a Th1 cytokine profile in bone cell damage associated with MMP-9 production in collagen-induced arthritis.
Chen J; Zhang XM; Xu Q
Inflamm Res; 2004 Dec; 53(12):670-9. PubMed ID: 15654515
[TBL] [Abstract][Full Text] [Related]
19. Arthritis in mice that are deficient in interleukin-1 receptor antagonist is dependent on genetic background.
Zhou F; He X; Iwakura Y; Horai R; Stuart JM
Arthritis Rheum; 2005 Dec; 52(12):3731-8. PubMed ID: 16320323
[TBL] [Abstract][Full Text] [Related]
20. Peptide-induced suppression of collagen-induced arthritis in HLA-DR1 transgenic mice.
Myers LK; Sakurai Y; Tang B; He X; Rosloniec EF; Stuart JM; Kang AH
Arthritis Rheum; 2002 Dec; 46(12):3369-77. PubMed ID: 12483744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
